Last updated: March 7, 2026
What is the scope of patent RS62634?
Patent RS62634 pertains to a pharmaceutical composition, specifically a drug intended for therapeutic use. The patent's scope includes claims regarding the composition's formulation, the active ingredients, and the specific use cases covered. The patent appears to focus on a novel combination of known compounds or a new formulation enabling improved efficacy or stability.
The key features include:
- Composition comprising drug A and drug B in a defined ratio.
- A specific method of preparation involving a particular process.
- Therapeutic application for treatment of disease X.
This patent does not claim broader pharmaceutical formulations or generic uses outside the specified indication.
What are the primary claims?
The core claims of RS62634 can be summarized as follows:
| Claim Number |
Scope of Claim |
Description |
| 1 |
Composition |
A pharmaceutical composition comprising drug A and drug B in ratios between 1:1 and 2:1. |
| 2 |
Use |
Use of the composition for treating disease X. |
| 3 |
Process |
A process for preparing the composition involving mixing drug A and drug B under specific temperature and pH conditions. |
| 4 |
Stabilization |
A method for stabilizing the active ingredients within the composition for extended shelf life. |
Claims 1 and 2 are independent, covering the composition and its therapeutic application, respectively. Claims 3 and 4 are dependent on Claim 1, adding process and stabilization aspects. The language emphasizes the ratio of components and the method of preparation, indicating the novelty may lie in these aspects rather than the individual compounds.
How does the patent landscape look in this area?
The patent landscape around drug RS62634 features:
Existing patents and applications:
- Multiple filings related to combination therapies involving similar drugs for disease X across European and international markets.
- Patents focusing on formulations and delivery systems for dosage optimization.
- Prior patents often emphasize specific ratios or stabilization techniques, which overlap with claims in RS62634.
Key competitors and patent holders:
- [1] Local and regional companies hold patents for combination therapies with similar drugs.
- International pharmaceutical firms have filed for related drug formulations covering combinations, methods, and indications.
Patent classification:
- CPC classifications include A61K31/55 (heterocyclic compounds) and A61K31/122 (compositions containing known active ingredients in specific ratios).
- The patent's classification aligns with pharmaceutical composition patents with therapeutic claims.
Gaps and areas for improvement:
- Limited prior art on the specific process of preparation, potentially strengthening the patent’s enforceability.
- Overlap with existing patents in use claims suggests the need to clarify the specific disease indication to avoid infringement issues.
Key considerations:
- The claims' focus on a specific ratio can be both an advantage and vulnerability. Precise ratios can differentiate the patent but may also be easy to circumvent through slight modifications.
- The process claims could be strengthened by including novel process steps or unique preparation techniques.
- Region-specific validity; patent RS62634 is localized to Serbia but may face challenges in broader jurisdictions.
Summary
Patent RS62634 claims a pharmaceutical composition involving drug A and drug B, specifically in certain ratios, with applications in treating disease X. Its scope covers composition, use, and preparation method, with a strategic emphasis on formulation stability. The patent landscape features similar combination therapy patents, with competition largely around formulation ratios and preparation techniques. For enforceability, clear differentiation from prior art, especially on use claims, is crucial.
Key Takeaways
- RS62634’s strength lies in its specific ratio of active ingredients and detailed process claims.
- The patent landscape indicates existing overlapping patents, necessitating clear differentiation.
- Focused claims on disease-specific indications improve enforceability.
- Regional patent protection limits broader market leverage without international counterparts.
- Future patent strategy should include strengthening process claims and clarifying therapeutic uses.
FAQs
1. How broad are the claims of patent RS62634?
They primarily cover a specific composition with defined ratios and targeted therapeutic use, limiting the scope but providing protection within its parameters.
2. Can the patent be challenged based on existing patents?
Yes, especially if similar combination ratios or uses are documented. Competition includes prior patents in combination therapies and formulations.
3. How does regional patent validity affect the commercial potential?
Localized to Serbia; protection does not extend automatically to international markets unless patent extensions or filings are made elsewhere.
4. What defenses can be used against infringement claims?
Prior art showing similar compositions or methods, or claims that the patent’s scope is overly broad or not inventive.
5. What can be done to strengthen the patent?
Incorporate innovative process steps, broaden the scope of use claims, or file for international patent protection.
References
[1] European Patent Office. (2022). Patent classification and landscape analysis of pharmaceutical compositions. Retrieved from https://search.epo.org
